Rational design of synthetic peptides to generate antibodies that recognize in situ CD11c (+) putative dendritic cells in horse lymph nodes

Espino-Solis, G.P.; Calderon-Amador, J.; Calderon-Aranda, E.S.; Licea, A.F.; Donis-Maturano, L.; Flores-Romo, L.; Possani, L.D.

Veterinary Immunology and Immunopathology 132(2-4): 181-190

2009


ISSN/ISBN: 1873-2534
PMID: 19682754
DOI: 10.1016/j.vetimm.2009.06.017
Accession: 055373675

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 0-6 h
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Abstract
A three-dimensional model of the alphaX I-domain of the horse integrin CD11c from dendritic cells provided information for selecting two segments of the primary structure for peptide synthesis. Peptide 1 contains 20 amino acids and peptide 2 has 17 amino acid residues. The first spans from position Thr229 to Arg248 of an alpha-helix segment of the structure, whereas peptide 2 goes from Asp158 to Phe174 and corresponds to an exposed segment of the loop considered to be the metal ion-dependent adhesion site. Murine polyclonal antisera against both peptides were generated and assayed in peripheral blood cell suspensions and in cryosections of horse lymph nodes. Only the serum against peptide 2 was capable of identifying cells in suspension and in situ by immunohistochemistry, some with evident dendritic morphology. Using this approach, an immunogenic epitope exposed in CD11c was identified in cells from horse lymph node in situ.